ImpediMed Limited
IPDQF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $101 | $193 | $338 | $125 |
| - Cash | $22 | $25 | $46 | $41 |
| + Debt | $14 | $1 | $1 | $0 |
| Enterprise Value | $94 | $170 | $293 | $84 |
| Revenue | $13 | $10 | $11 | $10 |
| % Growth | 26.6% | -11.4% | 8.1% | – |
| Gross Profit | $11 | $9 | -$14 | $9 |
| % Margin | 86.3% | 86.9% | -120.4% | 83.7% |
| EBITDA | -$18 | -$22 | -$20 | -$19 |
| % Margin | -138% | -219.3% | -180.7% | -178.8% |
| Net Income | -$23 | -$20 | -$21 | -$20 |
| % Margin | -182.6% | -196.9% | -180.9% | -189.4% |
| EPS Diluted | -0.012 | -0.01 | -0.011 | -0.012 |
| % Growth | -17.3% | 14% | 3.4% | – |
| Operating Cash Flow | -$15 | -$18 | -$18 | -$16 |
| Capital Expenditures | -$1 | -$3 | -$6 | -$5 |
| Free Cash Flow | -$16 | -$21 | -$24 | -$21 |